MEMPHIS PHARMACEUTICALS & CHEMICAL INDUSTRIES

Cash flow Memphis Pharmaceuticals & Chemical Industries

Equities

MPCI

EGS38351C010

Pharmaceuticals

End-of-day quote Egyptian Exchange Other stock markets 2026-05-06			5-day change	1st Jan Change
185.07 ^EGP	+1.36%		+7.78%	+18.48%

May. 03	Memphis Pharmaceuticals and Chemical Industries 9-month net profit EGP 388.8 million	RE
Feb. 17	Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2025	CI

d93e79.ZZsSMc8sf6RDFd218Et0Hq1faW9Ynv3F4J__KhKzJ0o.U-1xfLllJ8wze7HvuwlEfZowJQE257iBuPqQTGfCeDtd7XoErR0azjoslA

Published financial data: MEMPHIS PHARMACEUTICALS & CHEMICAL INDUSTRIES

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: June	2021	2022	2023	2024	2025
Revenues	518M	551M	664M	872M	1.51B
Other Revenues, Total	-	-	-	-	-
Total Revenues	518M	551M	664M	872M	1.51B
Cost of Goods Sold, Total	353M	402M	451M	573M	828M
Gross Profit	165M	149M	213M	298M	680M
Selling General & Admin Expenses, Total	75.98M	71.8M	77.41M	87.87M	99.02M
Provision for Bad Debts	-	-	-	-	-
Other Operating Expenses	54.86M	8.55M	39.61M	25.15M	58.61M
Other Operating Expenses, Total	131M	80.35M	117M	113M	158M
Operating Income	34.13M	69.04M	95.94M	185M	522M
Interest Expense, Total	-	-	-	-14.26M	-13.51M
Interest And Investment Income	5.41M	7.28M	11.13M	55.65M	136M
Net Interest Expenses	5.41M	7.28M	11.13M	41.4M	123M
Other Non Operating Income (Expenses)	2.11M	2M	2.96M	2.65M	6.56M
EBT, Excl. Unusual Items	41.65M	78.32M	110M	230M	652M
Gain (Loss) On Sale Of Assets	-	-	-	-	435K
Other Unusual Items	-	-	-45.22K	-	-
EBT, Incl. Unusual Items	41.65M	78.32M	110M	230M	652M
Income Tax Expense	-154K	4.23M	19.55M	38.06M	147M
Earnings From Continuing Operations	41.81M	74.09M	90.44M	191M	505M
Net Income to Company	41.81M	74.09M	90.44M	191M	505M
Net Income - (IS)	41.81M	74.09M	90.44M	191M	505M
Net Income to Common Incl Extra Items	41.81M	74.09M	90.44M	191M	505M
Net Income to Common Excl. Extra Items	41.81M	74.09M	90.44M	191M	505M
Per Share Items
Net EPS - Basic	-	13.17	16.08	34.04	22.21
Basic EPS - Continuing Operations	-	13.17	16.08	34.04	22.21
Basic Weighted Average Shares Outstanding	-	5.62M	5.62M	5.62M	22.75M
Net EPS - Diluted	-	13.17	16.08	34.04	22.21
Diluted EPS - Continuing Operations	-	13.17	16.08	34.04	22.21
Diluted Weighted Average Shares Outstanding	-	5.62M	5.62M	5.62M	22.75M
Normalized Basic EPS	-	8.7	12.23	25.5	17.91
Normalized Diluted EPS	-	8.7	12.23	25.5	17.91
Dividend Per Share	-	-	2	4	13.19
Payout Ratio	0.6	-	-	6.35	5.05
Supplemental Items
EBITDA	43.88M	76.68M	104M	198M	542M
EBITA	34.13M	72.67M	99.57M	189M	526M
EBIT	34.13M	69.04M	95.94M	185M	522M
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	-0.37	5.4	17.77	16.58	22.54
Total Current Taxes	-	4.03M	19.79M	37.25M	148M
Total Deferred Taxes	-154K	196K	-246K	807K	-833K
Normalized Net Income	26.03M	48.95M	68.77M	143M	407M
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	-
Selling and Marketing Expenses	45.5M	42.76M	44.62M	52.65M	59.18M
General and Administrative Expenses	30.48M	29.04M	32.79M	35.22M	39.84M
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	52.6M	83.83M	144M	520M	679M
Total Cash And Short Term Investments	52.6M	83.83M	144M	520M	679M
Accounts Receivable, Total	27.92M	78.96M	157M	338M	262M
Other Receivables	28.3M	40.02M	53.2M	-	-
Notes Receivable	84.13M	89.5M	113M	-	-
Total Receivables	140M	208M	323M	338M	262M
Inventory	161M	173M	221M	255M	453M
Prepaid Expenses	489K	1.6M	555K	-	-
Other Current Assets, Total	4.35M	14.14M	12.27M	-	-
Total Current Assets	358M	481M	700M	1.11B	1.39B
Gross Property Plant And Equipment	217M	230M	243M	262M	291M
Accumulated Depreciation	-172M	-176M	-180M	-175M	-204M
Net Property Plant And Equipment	44.49M	54.63M	63.5M	86.48M	86.9M
Long-term Investments	6.49M	6.49M	6.49M	6.49M	6.49M
Other Intangibles, Total	19.73M	16.1M	12.46M	8.83M	5.2M
Deferred Tax Assets Long-Term	2.47M	2.47M	2.72M	2.72M	1.1M
Other Long-Term Assets, Total	-	1	-	-	-1
Total Assets	432M	560M	786M	1.22B	1.49B
Liabilities
Accounts Payable, Total	402M	461M	589M	694M	355M
Accrued Expenses, Total	9.34M	10.15M	12.34M	13.89M	-
Short-term Borrowings	5.36M	4.73M	10.98M	69.27M	21.91M
Unearned Revenue Current, Total	-	-	93K	93K	-
Other Current Liabilities	50.6M	45.77M	64.27M	178M	273M
Total Current Liabilities	467M	522M	677M	956M	649M
Long-Term Debt	-	-	2.34M	110M	73.03M
Deferred Tax Liability Non Current	1.37M	1.57M	1.57M	2.45M	-
Other Non Current Liabilities	1.11M	-	-	-	1
Total Liabilities	470M	524M	681M	1.07B	722M
Common Stock, Total	56.25M	56.25M	56.25M	56.25M	228M
Retained Earnings	-97.52M	-22.7M	45.61M	89.34M	540M
Comprehensive Income and Other	3.09M	3.09M	3.09M	3.49M	3.49M
Total Common Equity	-38.18M	36.64M	105M	149M	771M
Total Equity	-38.18M	36.64M	105M	149M	771M
Total Liabilities And Equity	432M	560M	786M	1.22B	1.49B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	5.62M	5.62M	5.62M	22.75M
ECS Total Common Shares Outstanding	-	5.62M	5.62M	5.62M	22.75M
Book Value / Share	-	6.51	18.66	26.5	33.87
Tangible Book Value	-57.92M	20.55M	92.49M	140M	765M
Tangible Book Value Per Share	-	3.65	16.44	24.93	33.64
Total Debt	5.36M	4.73M	13.32M	179M	94.94M
Net Debt	-47.23M	-79.1M	-130M	-341M	-584M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	-	6	3	-	3
Inventories - Raw Materials, Total	-	-	-	-	328M
Inventories - Work In Process, Total	-	-	-	-	34.05M
Inventories - Finished Goods, Total	-	-	-	-	86.9M
Inventories - Others	-	-	-	-	7.77M
Land - (BS)	595K	595K	595K	595K	595K
Buildings, Total	59.6M	60.56M	61.23M	93.19M	99.35M
Machinery, Total	141M	142M	143M	148M	179M
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	-	-	-	-	-

Fiscal Period: June	2021	2022	2023	2024	2025
Net Income	41.81M	74.09M	90.44M	191M	505M
Depreciation & Amortization - CF	-	4.01M	4.12M	8.55M	16.19M
Amortization of Goodwill and Intangible Assets - (CF)	-	3.63M	3.63M	3.63M	3.63M
Depreciation & Amortization, Total	-	7.64M	7.75M	12.18M	19.82M
Other Operating Activities, Total	-38.33M	-45.26M	-40.25M	-20.43M	-438M
Cash from Operations	3.47M	36.47M	57.94M	183M	86.89M
Capital Expenditure	-2.07M	-12.92M	-11.45M	-24.37M	-21.23M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Other Investing Activities, Total	4.68M	7.69M	10.87M	54.97M	132M
Cash from Investing	2.62M	-5.24M	-582K	30.59M	111M
Long-Term Debt Issued, Total	-	-	2.34M	175M	-
Total Debt Issued	-	-	2.34M	175M	-
Long-Term Debt Repaid, Total	-	-	-	-	-82.11M
Total Debt Repaid	-	-	-	-	-82.11M
Issuance of Common Stock	-	-	-	-	68.41M
Common Dividends Paid	-250K	-	-	-12.17M	-25.51M
Common & Preferred Stock Dividends Paid	-250K	-	-	-12.17M	-25.51M
Cash from Financing	-250K	-	2.34M	163M	-39.21M
Miscellaneous Cash Flow Adjustments	-	1	-	-4K	1
Net Change in Cash	5.84M	31.23M	59.7M	376M	159M
Supplemental Items
Cash Interest Paid	-	-	36.79M	14.26M	13.51M
Cash Income Tax Paid (Refund)	9.38M	7.04M	22.41M	24.84M	73.84M
Levered Free Cash Flow	-1.42M	2.33M	44.55M	280M	-66.35M
Unlevered Free Cash Flow	-1.42M	2.33M	44.55M	289M	-57.9M
Change In Net Working Capital	20.69M	35.54M	11.72M	-185M	383M
Net Debt Issued / Repaid	-	-	2.34M	175M	-82.11M

Fiscal Period: June	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.27	8.7	8.91	11.58	24.1
Return on Total Capital	-40.92	1.01K	75.12	51.96	54.8
Return On Equity %	-71.43	-9.62K	127.74	150.74	109.89
Return on Common Equity	-71.43	-9.62K	127.74	150.74	109.89
Margin Analysis
Gross Profit Margin %	31.84	27.1	32.08	34.23	45.1
SG&A Margin	14.66	13.03	11.66	10.08	6.57
EBITDA Margin %	8.47	13.91	15.62	22.67	35.96
EBITA Margin %	6.59	13.18	15	21.69	34.88
EBIT Margin %	6.59	12.52	14.45	21.27	34.64
Income From Continuing Operations Margin %	8.07	13.44	13.62	21.96	33.51
Net Income Margin %	8.07	13.44	13.62	21.96	33.51
Net Avail. For Common Margin %	8.07	13.44	13.62	21.96	33.51
Normalized Net Income Margin	5.02	8.88	10.36	16.45	27.02
Levered Free Cash Flow Margin	-0.27	0.42	6.71	32.11	-4.4
Unlevered Free Cash Flow Margin	-0.27	0.42	6.71	33.13	-3.84
Asset Turnover
Asset Turnover	1.28	1.11	0.99	0.87	1.11
Fixed Assets Turnover	11.69	11.12	11.24	11.63	17.39
Receivables Turnover (Average Receivables)	14.56	10.32	5.64	2.59	5.03
Inventory Turnover (Average Inventory)	2.6	2.41	2.29	2.41	2.34
Short Term Liquidity
Current Ratio	0.77	0.92	1.04	1.16	2.15
Quick Ratio	0.23	0.39	0.52	0.9	1.45
Operating Cash Flow to Current Liabilities	0.01	0.07	0.09	0.19	0.13
Days Sales Outstanding (Average Receivables)	25.08	35.38	64.74	141.44	72.63
Days Outstanding Inventory (Average Inventory)	140.5	151.3	159.39	151.83	155.89
Average Days Payable Outstanding	336.95	380.79	383.8	387.09	176.89
Cash Conversion Cycle (Average Days)	-171.38	-194.1	-159.67	-93.82	51.63
Long Term Solvency
Total Debt/Equity	-14.04	12.91	12.69	119.95	12.32
Total Debt / Total Capital	-16.34	11.44	11.26	54.53	10.97
LT Debt/Equity	-	-	2.23	73.48	9.48
Long-Term Debt / Total Capital	-	-	1.98	33.41	8.44
Total Liabilities / Total Assets	108.85	93.46	86.64	87.75	48.38
EBIT / Interest Expense	-	-	-	13.01	38.65
EBITDA / Interest Expense	-	-	-	13.86	40.12
(EBITDA - Capex) / Interest Expense	-	-	-	12.15	38.55
Total Debt / EBITDA	0.12	0.06	0.13	0.9	0.18
Net Debt / EBITDA	-1.08	-1.03	-1.26	-1.73	-1.08
Total Debt / (EBITDA - Capex)	0.13	0.07	0.14	1.03	0.18
Net Debt / (EBITDA - Capex)	-1.13	-1.24	-1.41	-1.97	-1.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.08	6.4	20.42	31.34	72.93
Gross Profit, 1 Yr. Growth %	79	-9.45	42.55	40.17	126.44
EBITDA, 1 Yr. Growth %	106.11	74.75	35.23	90.7	142.49
EBITA, 1 Yr. Growth %	123.88	112.89	44.23	97.2	148.81
EBIT, 1 Yr. Growth %	193.93	102.25	38.97	93.41	147.09
Earnings From Cont. Operations, 1 Yr. Growth %	140.14	77.22	22.07	111.7	163.91
Net Income, 1 Yr. Growth %	140.14	77.22	22.07	111.7	163.91
Normalized Net Income, 1 Yr. Growth %	136.77	88.03	40.49	108.68	184.02
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	22.07	111.7	-34.75
Accounts Receivable, 1 Yr. Growth %	-35.48	182.82	99.39	0.71	-22.55
Inventory, 1 Yr. Growth %	44.4	7.43	28.2	15.06	77.82
Net Property, Plant and Equip., 1 Yr. Growth %	0.72	22.8	16.23	36.2	0.49
Total Assets, 1 Yr. Growth %	14.35	29.82	40.22	54.91	22.66
Tangible Book Value, 1 Yr. Growth %	-43.35	-135.47	350.17	51.64	445.7
Common Equity, 1 Yr. Growth %	-51.58	-195.96	186.42	42.05	416.86
Cash From Operations, 1 Yr. Growth %	-209.06	950.33	58.88	216.2	-52.57
Capital Expenditures, 1 Yr. Growth %	159.15	524.59	-11.38	112.85	-12.88
Levered Free Cash Flow, 1 Yr. Growth %	-104.28	-264.37	-938.95	661.58	-123.22
Unlevered Free Cash Flow, 1 Yr. Growth %	-104.28	-264.37	-938.95	685.82	-119.65
Dividend Per Share, 1 Yr. Growth %	-	-	-	100	229.68
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	19.46	6.24	13.19	25.76	50.71
Gross Profit, 2 Yr. CAGR %	153.14	27.32	13.61	41.35	78.69
EBITDA, 2 Yr. CAGR %	30.44	89.79	53.72	60.55	128.71
EBITA, 2 Yr. CAGR %	-1.77	118.32	70.79	65.5	134.2
EBIT, 2 Yr. CAGR %	-1.77	143.82	67.65	63.91	133.39
Earnings From Cont. Operations, 2 Yr. CAGR %	28.35	106.3	47.08	60.76	136.37
Net Income, 2 Yr. CAGR %	28.35	106.3	47.08	60.76	136.37
Normalized Net Income, 2 Yr. CAGR %	21.9	110.99	62.53	71.19	143.45
Diluted EPS Before Extra, 2 Yr. CAGR %	-	106.3	-	60.76	17.53
Accounts Receivable, 2 Yr. CAGR %	8.2	35.08	137.01	107.33	-11.68
Inventory, 2 Yr. CAGR %	35.78	24.55	17.36	21.45	43.04
Net Property, Plant and Equip., 2 Yr. CAGR %	1.33	11.22	19.47	25.82	16.99
Total Assets, 2 Yr. CAGR %	12.21	21.84	34.92	47.38	37.84
Tangible Book Value, 2 Yr. CAGR %	-21.13	-55.17	26.37	161.27	187.66
Common Equity, 2 Yr. CAGR %	-24	-31.84	65.79	101.7	170.96
Cash From Operations, 2 Yr. CAGR %	-5.06	238.46	308.51	124.14	22.46
Capital Expenditures, 2 Yr. CAGR %	44.89	302.32	135.26	37.34	36.18
Levered Free Cash Flow, 2 Yr. CAGR %	-81.51	-73.49	460.14	626.17	34.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	-81.74	-73.49	460.14	637.63	25.5
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	156.78
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	15.12	14.94	10.77	18.95	39.85
Gross Profit, 3 Yr. CAGR %	121.89	79.7	32.2	21.85	65.73
EBITDA, 3 Yr. CAGR %	4.4	43.8	69.51	65.15	91.93
EBITA, 3 Yr. CAGR %	-8.4	27.12	86.92	76.94	96.77
EBIT, 3 Yr. CAGR %	-10.77	24.97	102.15	75.8	96.32
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.65	42.92	73.19	66.07	89.64
Net Income, 3 Yr. CAGR %	-3.65	42.92	73.19	66.07	89.64
Normalized Net Income, 3 Yr. CAGR %	-1.57	40.85	84.25	76.63	102.66
Diluted EPS Before Extra, 3 Yr. CAGR %	-	42.92	73.19	-	19.03
Accounts Receivable, 3 Yr. CAGR %	-0.34	49.04	53.61	129.65	49.32
Inventory, 3 Yr. CAGR %	10.78	25.58	25.76	16.59	37.91
Net Property, Plant and Equip., 3 Yr. CAGR %	-2.66	8.03	12.86	24.81	16.73
Total Assets, 3 Yr. CAGR %	4.77	17.8	27.68	41.28	38.63
Tangible Book Value, 3 Yr. CAGR %	-3.66	-39.57	-3.28	34.29	233.97
Common Equity, 3 Yr. CAGR %	3.81	-17.86	9.99	57.46	176.02
Cash From Operations, 3 Yr. CAGR %	-43.52	111.54	163.04	275.08	33.56
Capital Expenditures, 3 Yr. CAGR %	75.17	135.81	142.97	127.54	18.01
Levered Free Cash Flow, 3 Yr. CAGR %	-61.47	-61.7	10.3	482.07	132.05
Unlevered Free Cash Flow, 3 Yr. CAGR %	-61.72	-62.02	10.3	488.18	121.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.94	17.31	14.34	19.15	25.29
Gross Profit, 5 Yr. CAGR %	42.57	59.78	69.77	63.25	49.14
EBITDA, 5 Yr. CAGR %	76.45	20.1	21.88	50.28	91.07
EBITA, 5 Yr. CAGR %	53.28	14.44	17.52	39.83	103.03
EBIT, 5 Yr. CAGR %	53.28	12.04	14.83	39.29	114.09
Earnings From Cont. Operations, 5 Yr. CAGR %	242.56	16.71	14.11	49.8	96.13
Net Income, 5 Yr. CAGR %	242.56	16.71	14.11	49.8	96.13
Normalized Net Income, 5 Yr. CAGR %	107.18	16.51	20.29	52.28	105.95
Diluted EPS Before Extra, 5 Yr. CAGR %	-	16.71	14.11	49.8	48.31
Accounts Receivable, 5 Yr. CAGR %	-10.37	23.56	40.94	69.95	43.34
Inventory, 5 Yr. CAGR %	10.17	3.67	13.37	23.91	32.4
Net Property, Plant and Equip., 5 Yr. CAGR %	-5.36	0.74	5.66	14.82	14.5
Total Assets, 5 Yr. CAGR %	6.59	11.12	15.93	28.84	31.65
Tangible Book Value, 5 Yr. CAGR %	-1.36	25.96	7.39	8.54	49.57
Common Equity, 5 Yr. CAGR %	-9.24	5.69	25.19	17.66	57.75
Cash From Operations, 5 Yr. CAGR %	-17.4	45.39	24.63	116.5	93.74
Capital Expenditures, 5 Yr. CAGR %	10.69	56.11	97.1	89.96	92.74
Levered Free Cash Flow, 5 Yr. CAGR %	-37.39	-50.62	12.42	46.47	14.85
Unlevered Free Cash Flow, 5 Yr. CAGR %	-37.39	-50.62	11.97	46.65	11.77